Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CTNNB1 |
Variant | G38fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | CTNNB1 G38fs results in a change in the amino acid sequence of the Ctnnb1 protein beginning at aa 38 of 781, likely resulting in a truncation of the functional protein (UniProt.org). Due to the loss of all known functional domains (UniProt.org), G38fs is predicted to lead to a loss of Ctnnb1 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
CTNNB1 mutant CTNNB1 inact mut CTNNB1 G38fs |
Transcript | NM_001098210.2 |
gDNA | chr3:g.(41224623_41224624) |
cDNA | c.(112_111) |
Protein | p.G38fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001098209.2 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_024453357.1 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_024453356.1 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_024453356.2 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_006712985.2 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_017005738 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
NM_001904.4 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
NM_001098210.1 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_006712985 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_006712985.1 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
NM_001098210.2 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_047447477.1 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_047447478.1 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
NM_001098209.1 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_005264886 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
NM_001904 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_024453358.1 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
NM_001098210 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_017005738.2 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_047447483.1 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_017005738.1 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_047447481.1 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
NM_001098209 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_047447479.1 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
NM_001904.3 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
XM_047447480.1 | chr3:g.(41224623_41224624) | c.(112_111) | p.G38fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|